WallStSmart

Api Group Corp (APG)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Api Group Corp generates 154% more annual revenue ($8.17B vs $3.22B). WST leads profitability with a 16.9% profit margin vs 4.0%. WST earns a higher WallStSmart Score of 67/100 (B-).

APG

Hold

49

out of 100

Grade: D+

Growth: 8.0Profit: 5.5Value: 4.0Quality: 5.5
Piotroski: 5/9Altman Z: 1.69

WST

Strong Buy

67

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 2.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APGSignificantly Overvalued (-23.3%)

Margin of Safety

-23.3%

Fair Value

$36.50

Current Price

$44.67

$8.17 premium

UndervaluedFair: $36.50Overvalued
WSTSignificantly Overvalued (-32.8%)

Margin of Safety

-32.8%

Fair Value

$185.39

Current Price

$312.55

$127.16 premium

UndervaluedFair: $185.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Revenue GrowthGrowth
15.3%8/10

15.3% revenue growth

WST4 strengths · Avg: 9.0/10
EPS GrowthGrowth
56.1%10/10

Earnings expanding 56.1% YoY

Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.7%8/10

Strong operational efficiency at 21.7%

Revenue GrowthGrowth
21.0%8/10

Revenue surging 21.0% year-over-year

Areas to Watch

APG2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

WST2 concerns · Avg: 2.0/10
PEG RatioValuation
2.892/10

Expensive relative to growth rate

P/E RatioValuation
40.1x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : APG

The strongest argument for APG centers on EPS Growth, Revenue Growth. Revenue growth of 15.3% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.

Bear Case : APG

The primary concerns for APG are Altman Z-Score, Profit Margin. Thin 4.0% margins leave little buffer for downturns.

Bear Case : WST

The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 40.1x leaves little room for execution misses.

Key Dynamics to Monitor

APG carries more volatility with a beta of 1.69 — expect wider price swings.

WST is growing revenue faster at 21.0% — sustainability is the question.

APG generates stronger free cash flow (67M), providing more financial flexibility.

Monitor ENGINEERING & CONSTRUCTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WST scores higher overall (67/100 vs 49/100), backed by strong 16.9% margins and 21.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Api Group Corp

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

APi Group Corporation provides security, specialty and industrial services primarily in North America. The company is headquartered in New Brighton, Minnesota.

Visit Website →

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?